论文部分内容阅读
在经历了2004年的产值、效益增速大幅下滑后,面对依然严峻的上游原材料成本上涨压力,以及药品价格持续下行的巨大挑战,2005年医药行业呈现明显的复苏态势,产值、销售增幅创下“十五”期内新高,由于同期成本费用同步高涨,利润增幅虽比上年有较大幅度提高,但仍低于“十五”平均水平.
医药行业2005年运行分析及2006年发展预测
【摘 要】
：
在经历了2004年的产值、效益增速大幅下滑后,面对依然严峻的上游原材料成本上涨压力,以及药品价格持续下行的巨大挑战,2005年医药行业呈现明显的复苏态势,产值、销售增幅创下
【出 处】
：
中国医药工业杂志
【发表日期】
：
2006年3期
其他文献
注射用夫西地酸钠(国药准字H20058151,成都天台山制药)为白色疏松块状物,主要用于各种敏感菌引起的感染。如败血症、反复感染肺炎、骨髓炎、心内膜炎外伤及创伤性感
Sodium
Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma pat
Objective:Anti-angiogenic drugs are an emerging treatment option against malignant tumors.The aim of this study was to determine whether the addition of periope
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR
Objective:SHR-1210 is a new and promising anti-PD-1 agent for solid tumors.During the phase Ⅰ study of SHR-1210,we encountered a novel but prevalent immune-rel
Methods of computed tomography screening and management of lung cancer in Tianjin: design of a popul
Objective:European lung cancer screening studies using computed tomography (CT) have shown that a management protocol based on measuring lung nodule volume and
Application of next-generation sequencing technology to precision medicine in cancer: joint consensu
Next-generation sequencing (NGS) technology is capable of sequencing millions or billions of DNA molecules simultaneously.Therefore,it represents a promising to